Delivery Order SPE2DB22D1106-SPE2DB24FFDB0

Award Date 7/19/24
Potential Completion Date 7/22/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,774.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. It is a firm-fixed-price delivery order with a performance period extending through May 6, 2025. This award is not associated with a set-aside program and represents open...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $1,924.48. It does not have a set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,935.66, is for the delivery of FYCOMPA 0.5 mg/ml oral suspension (340 ml). The contract is a Firm Fixed Price Delivery Order with a completion date of February 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,214.22 Firm Fixed Price contract is a Delivery Order to supply the medication FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has an ultimate completion date of October 11, 2024 and was awarded on October 10, 2024. The contract is not designated as a set-aside and represents open competition. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML. The contract has a ceiling value of $9,200.92 and a completion date of February 27, 2025. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,096.77, is for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 31, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,240.52 delivery order contract is for the supply of FYCOMPA 8 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,848.96, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to the corporate office of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication, to the DLA. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation. Amerisourcebergen holds a larger...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of FYCOMPA 0.5 mg/ml oral suspension in 340 ml bottles, a prescription medication used to treat seizures. The contract is a delivery order with a firm fixed price of $3,040.05 and a completion date of December 17, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a large...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of FYCOMPA 12 MG TABLET 30S, a pharmaceutical product. The contract has a ceiling value of $1,279.57 and an ultimate completion date of October 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical,...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFDB0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $3,848.96 and is a Firm Fixed Price Delivery Order for the supply of FYCOMPA 0.5 MG/ML ORAL SUSP 340ML, a prescription medication. The contract has an ultimate completion date of July 22, 2024. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is not designated as a set-aside. This award is likely part of a larger Indefinite Delivery Contract (IDC) the company has with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide.

Generated 10/18/24, 9:23 AM